Cell Therapy Augments Myocardial Perfusion and Improves Quality of Life in Patients With Refractory Angina

Circ Res. 2016 Mar 18;118(6):911-5. doi: 10.1161/CIRCRESAHA.116.308409.

Authors

Victoria Florea¹, Wayne Balkan¹, Ivonne Hernandez Schulman¹, Joshua M Hare²

Affiliations

¹ From The Interdisciplinary Stem Cell Institute (V.F., W.B., I.H.S., J.M.H.) and Department of Medicine (W.B., I.H.S., J.M.H.), University of Miami, Miller School of Medicine, FL.
² From The Interdisciplinary Stem Cell Institute (V.F., W.B., I.H.S., J.M.H.) and Department of Medicine (W.B., I.H.S., J.M.H.), University of Miami, Miller School of Medicine, FL. jhare@med.miami.edu.

No abstract available

Keywords: Editorial; angina; angiogenesis; meta-analysis; perfusion.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Angina Pectoris / physiopathology*
Angina Pectoris / therapy*
Cell- and Tissue-Based Therapy / methods*
Humans
Percutaneous Coronary Intervention / methods*

Grants and funding